tradingkey.logo

Neuropace Inc

NPCE
15.670USD
+0.180+1.16%
종가 02/06, 16:00ET시세는 15분 지연됩니다
521.51M시가총액
손실P/E TTM

Neuropace Inc

15.670
+0.180+1.16%

자세한 내용은 Neuropace Inc 회사

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Neuropace Inc 정보

종목 코드 NPCE
회사 이름Neuropace Inc
상장일Apr 22, 2021
CEOBecker (Joel D)
직원 수184
유형Ordinary Share
회계 연도 종료Apr 22
주소455 N. Bernardo Avenue
도시MOUNTAIN VIEW
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94043
전화16502372700
웹사이트https://www.neuropace.com/
종목 코드 NPCE
상장일Apr 22, 2021
CEOBecker (Joel D)

Neuropace Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
593.35K
+1431.00%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
64.90K
-1338.00%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
+51850.00%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
39.16K
+678.00%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
18.01K
+904.00%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
13.95K
+715.00%
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
593.35K
+1431.00%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
64.90K
-1338.00%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
+51850.00%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
39.16K
+678.00%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
18.01K
+904.00%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
13.95K
+715.00%

수익 분석

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2022
FY2021
FY2020
FY2019
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
27.35M
0.00%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
Accelmed Growth Partners Management Ltd
13.40%
Polar Capital LLP
9.36%
Soleus Capital Management, L.P.
8.94%
OrbiMed Advisors, LLC
7.90%
Morgan Stanley & Co. LLC
7.67%
기타
52.72%
주주
주주
비율
Accelmed Growth Partners Management Ltd
13.40%
Polar Capital LLP
9.36%
Soleus Capital Management, L.P.
8.94%
OrbiMed Advisors, LLC
7.90%
Morgan Stanley & Co. LLC
7.67%
기타
52.72%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
25.91%
Private Equity
21.30%
Hedge Fund
19.29%
Investment Advisor
17.23%
Research Firm
8.41%
Individual Investor
2.72%
Pension Fund
0.29%
Bank and Trust
0.08%
Venture Capital
0.03%
기타
4.75%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
209
30.65M
92.64%
-6.33M
2025Q3
198
31.14M
94.13%
-2.95M
2025Q2
184
29.13M
88.81%
-1.17M
2025Q1
183
29.76M
92.98%
+2.27M
2024Q4
144
26.53M
86.07%
-49.99K
2024Q3
134
26.01M
86.62%
-1.02M
2024Q2
129
25.88M
90.53%
+502.69K
2024Q1
131
24.82M
87.55%
-513.24K
2023Q4
113
24.06M
92.70%
-1.70M
2023Q3
103
24.86M
97.20%
-1.10M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Accelmed Growth Partners Management Ltd
4.43M
13.4%
--
--
Apr 09, 2025
Polar Capital LLP
3.10M
9.36%
--
--
Sep 30, 2025
Soleus Capital Management, L.P.
2.96M
8.94%
+645.00K
+27.89%
Sep 30, 2025
OrbiMed Advisors, LLC
2.61M
7.9%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
2.54M
7.67%
-38.81K
-1.51%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.64M
4.95%
+103.79K
+6.76%
Sep 30, 2025
The Vanguard Group, Inc.
1.44M
4.34%
+66.57K
+4.86%
Sep 30, 2025
First Light Asset Management, LLC
1.36M
4.11%
-20.34K
-1.47%
Sep 30, 2025
Armistice Capital LLC
1.30M
3.92%
+145.66K
+12.64%
Sep 30, 2025
Kent Lake PR LLC
1.00M
3.02%
+75.00K
+8.11%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Neuroscience and Healthcare ETF
0.64%
Principal U.S. Small-Cap ETF
0.05%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Proshares Ultra Russell 2000
0.01%
더 보기
iShares Neuroscience and Healthcare ETF
비율0.64%
Principal U.S. Small-Cap ETF
비율0.05%
iShares Micro-Cap ETF
비율0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0.02%
ProShares Hedge Replication ETF
비율0.02%
ProShares UltraPro Russell2000
비율0.01%
iShares Russell 2000 ETF
비율0.01%
iShares Russell 2000 Growth ETF
비율0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
비율0.01%
Proshares Ultra Russell 2000
비율0.01%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI